Search

Roger L Pang

Examiner (ID: 12496, Phone: (571)272-7096 , Office: P/3655 )

Most Active Art Unit
3655
Art Unit(s)
3681, 3622, 3655
Total Applications
2464
Issued Applications
2143
Pending Applications
72
Abandoned Applications
249

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3937704 [patent_doc_number] => 05872007 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer' [patent_app_type] => 1 [patent_app_number] => 8/502374 [patent_app_country] => US [patent_app_date] => 1995-07-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 9539 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 294 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872007.pdf [firstpage_image] =>[orig_patent_app_number] => 502374 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/502374
CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer Jul 13, 1995 Issued
Array ( [id] => 3648591 [patent_doc_number] => 05639736 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-17 [patent_title] => 'Human VEGF-specific oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/502185 [patent_app_country] => US [patent_app_date] => 1995-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 11177 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/639/05639736.pdf [firstpage_image] =>[orig_patent_app_number] => 502185 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/502185
Human VEGF-specific oligonucleotides Jul 12, 1995 Issued
Array ( [id] => 3695650 [patent_doc_number] => 05661135 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-26 [patent_title] => 'Human VEGF-specific oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/501779 [patent_app_country] => US [patent_app_date] => 1995-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 11172 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/661/05661135.pdf [firstpage_image] =>[orig_patent_app_number] => 501779 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/501779
Human VEGF-specific oligonucleotides Jul 12, 1995 Issued
Array ( [id] => 3813533 [patent_doc_number] => 05710136 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-01-20 [patent_title] => 'Inhibition of neovascularization using VEGF-specific oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/501713 [patent_app_country] => US [patent_app_date] => 1995-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 11168 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/710/05710136.pdf [firstpage_image] =>[orig_patent_app_number] => 501713 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/501713
Inhibition of neovascularization using VEGF-specific oligonucleotides Jul 11, 1995 Issued
Array ( [id] => 3791207 [patent_doc_number] => 05726050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Z-DNA binding protein and applications' [patent_app_type] => 1 [patent_app_number] => 8/492599 [patent_app_country] => US [patent_app_date] => 1995-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 5 [patent_no_of_words] => 7870 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726050.pdf [firstpage_image] =>[orig_patent_app_number] => 492599 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/492599
Z-DNA binding protein and applications Jun 19, 1995 Issued
Array ( [id] => 3625051 [patent_doc_number] => 05689050 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-18 [patent_title] => 'Production of gamma linolenic acid by a .DELTA.6-desaturase' [patent_app_type] => 1 [patent_app_number] => 8/473508 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 6400 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/689/05689050.pdf [firstpage_image] =>[orig_patent_app_number] => 473508 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/473508
Production of gamma linolenic acid by a .DELTA.6-desaturase Jun 6, 1995 Issued
Array ( [id] => 4007707 [patent_doc_number] => 05859309 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Vector for integration site independent gene expression in mammalian host cells' [patent_app_type] => 1 [patent_app_number] => 8/481035 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 9060 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859309.pdf [firstpage_image] =>[orig_patent_app_number] => 481035 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/481035
Vector for integration site independent gene expression in mammalian host cells Jun 6, 1995 Issued
Array ( [id] => 3774637 [patent_doc_number] => 05849997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Vector for integration site independent gene expression in mammalian host cells' [patent_app_type] => 1 [patent_app_number] => 8/478501 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 37 [patent_no_of_words] => 10958 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849997.pdf [firstpage_image] =>[orig_patent_app_number] => 478501 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/478501
Vector for integration site independent gene expression in mammalian host cells Jun 6, 1995 Issued
Array ( [id] => 3814675 [patent_doc_number] => 05770449 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Vector for integration site independent gene expression in mammalian host cells which permit immunoglobulin gene expression' [patent_app_type] => 1 [patent_app_number] => 8/483999 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 9028 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 234 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770449.pdf [firstpage_image] =>[orig_patent_app_number] => 483999 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/483999
Vector for integration site independent gene expression in mammalian host cells which permit immunoglobulin gene expression Jun 6, 1995 Issued
Array ( [id] => 3729039 [patent_doc_number] => 05635355 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-06-03 [patent_title] => 'Methods of obtaining a DNA sequence for integration site independent gene expression' [patent_app_type] => 1 [patent_app_number] => 8/478948 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 12177 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/635/05635355.pdf [firstpage_image] =>[orig_patent_app_number] => 478948 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/478948
Methods of obtaining a DNA sequence for integration site independent gene expression Jun 6, 1995 Issued
Array ( [id] => 3769496 [patent_doc_number] => 05756353 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Expression of cloned genes in the lung by aerosol-and liposome-based delivery' [patent_app_type] => 1 [patent_app_number] => 8/487793 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 8359 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756353.pdf [firstpage_image] =>[orig_patent_app_number] => 487793 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/487793
Expression of cloned genes in the lung by aerosol-and liposome-based delivery Jun 6, 1995 Issued
Array ( [id] => 3813907 [patent_doc_number] => 05770398 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-23 [patent_title] => 'Vector for integration site independent gene expression in mammalian host cells' [patent_app_type] => 1 [patent_app_number] => 8/483998 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 37 [patent_no_of_words] => 12219 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 185 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/770/05770398.pdf [firstpage_image] =>[orig_patent_app_number] => 483998 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/483998
Vector for integration site independent gene expression in mammalian host cells Jun 6, 1995 Issued
Array ( [id] => 3767743 [patent_doc_number] => 05849548 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-15 [patent_title] => 'Cell ablation using trans-splicing ribozymes' [patent_app_type] => 1 [patent_app_number] => 8/488031 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 30 [patent_no_of_words] => 16375 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/849/05849548.pdf [firstpage_image] =>[orig_patent_app_number] => 488031 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/488031
Cell ablation using trans-splicing ribozymes Jun 6, 1995 Issued
Array ( [id] => 3839769 [patent_doc_number] => 05744456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'Methods for obtaining production of a gene product in a host cell in vivo or in vitro using a DNA molecule for integration site independent gene expression' [patent_app_type] => 1 [patent_app_number] => 8/481034 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 35 [patent_no_of_words] => 10967 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 211 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744456.pdf [firstpage_image] =>[orig_patent_app_number] => 481034 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/481034
Methods for obtaining production of a gene product in a host cell in vivo or in vitro using a DNA molecule for integration site independent gene expression Jun 6, 1995 Issued
Array ( [id] => 3686618 [patent_doc_number] => 05663153 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Immune stimulation by phosphorothioate oligonucleotide analogs' [patent_app_type] => 1 [patent_app_number] => 8/467930 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8036 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663153.pdf [firstpage_image] =>[orig_patent_app_number] => 467930 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/467930
Immune stimulation by phosphorothioate oligonucleotide analogs Jun 5, 1995 Issued
Array ( [id] => 3686553 [patent_doc_number] => 05643788 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 8/479173 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 16 [patent_no_of_words] => 8906 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643788.pdf [firstpage_image] =>[orig_patent_app_number] => 479173 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/479173
Method of inhibiting the proliferation and causing the differentiation of cells with IGF-1 receptor antisense oligonucleotides Jun 5, 1995 Issued
Array ( [id] => 3693476 [patent_doc_number] => 05650307 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Production of heterologous proteins in plants and plant cells' [patent_app_type] => 1 [patent_app_number] => 8/469856 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8079 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650307.pdf [firstpage_image] =>[orig_patent_app_number] => 469856 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/469856
Production of heterologous proteins in plants and plant cells Jun 5, 1995 Issued
08/464417 ANTIBACTERIAL THERAPY WITH BACTERIOPHAGE GENOTYPICALLY MODIFIED TO DELAY INACTIVATION BY THE HOST DEFENSE SYSTEM Jun 4, 1995 Abandoned
Array ( [id] => 3698163 [patent_doc_number] => 05677289 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'Method of cleaving specific strands of RNA and medical treatments thereby' [patent_app_type] => 1 [patent_app_number] => 8/458050 [patent_app_country] => US [patent_app_date] => 1995-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24518 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677289.pdf [firstpage_image] =>[orig_patent_app_number] => 458050 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/458050
Method of cleaving specific strands of RNA and medical treatments thereby May 31, 1995 Issued
08/453085 COMPOSITIONS AND METHODS FOR TREATMENT OF HEPATITIS C VIRUS-ASSOCIATED DISEASES May 29, 1995 Abandoned
Menu